Ernexa Therapeutics Inc. (ERNA) financial statements and ratios from SEC XBRL. Income statement, balance sheet, cash flow, and valuation. First-party data.
| DCF Value (model) | $-235.05 |
| DCF Upside vs Price | -5017.4% |
| Altman Z-Score | -69.78 (distress) |
| Sector P/E (Healthcare) | 21.7 |
ERNA overview · ERNA earnings · ERNA KPIs · ERNA investor relations · ERNA ownership · ERNA peers · ERNA filings
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.